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Adrenergic regulation of phosphoinositide breakdown in rat skeletal muscle was investigated in 30-min in- 
cubations with 10 mM LiCl. In rat hemidiaphragms, prelabelled with D-myo-[2-3H]inositol, addition of 
a-agonists (epinephrine, norepinephrine, phenylephrine) induced a 5-8-fold increase of PH]inositol mono- 
phosphate accumulation. This could be prevented by inclusion of u-antagonists (phentolamine, prazosin). 
&Agonists and/or fi-antagonists had no effect. Similar experiments with isolated flexor digitorum brevis 
muscle fibers yielded confirmatory results. Functional integrity of p-receptor mediated processes was sug- 
gested by the /?-agonist-induced increase of glucose 6-phosphate in hemidiaphragms and CAMP in fiber 
preparations. The results indicate that phosphoinositide breakdown in differentiated rat skeletal muscle is, 
at least in part, under a-adrenergic ontrol. 
Phosphatidylinositol; a-Agonist; (Rat diaphragm, Muscle fiber) 
1. INTRODUCTION 
Receptor-mediated activation of membrane 
bound phospholipase C, which catalyses the 
hydrolysis of phosphatidylinositol 4,5-bisphos- 
phate, generates two second messengers. Diacyl- 
glycerol thus formed can activate protein kinase C, 
whereas inositol 1,4,5_trisphosphate is involved in 
the regulation of intracellular Ca2+ fluxes. The lat- 
ter compound can be rapidly inactivated and 
catabolized to inositol by specific monoesterases 
(review [l]). 
Using LiCl, a specific inhibitor of inositol 
phosphate hydrolysis at the inositol monophos- 
phate step, mu-adrenergic mechanisms have been 
shown to stimulate phosphoinositide breakdown in 
fat cells [2], hepatocytes [3], BC3H-1 cells [4], 
smooth muscle [5] and heart [6]. Whether this also 
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applies to differentiated skeletal muscle is 
unknown. 
This communication reports on a stimulatory ef- 
fect of cu-adrenergic agonists on inositol phosphate 
formation in hemidiaphragms and isolated flexor 
digitorum brevis muscle fibers of rat. 
2. MATERIALS AND METHODS 
Unless otherwise noted, all chemicals were pur- 
chased from Merck (Darmstadt), Serva (Heidel- 
berg) or Sigma (Miinchen). Phentolamine was 
from Ciba (Wehr) and prazosin was from Pfizer 
(Karlsruhe). Enzymes and coenzymes were from 
Boehringer (Mannheim) and D-myo-[2-3H]inositol 
(577-620 kBq/nmol), L-3-phosphatidyl-[2-3H]- 
inositol (603 kBq/nmol) and 3Hz0 standard from 
Amersham (Braunschweig). 
Fed male rats were used (100-150 g body wt). 
Hemidiaphragms were prelabelled with [3H]ino- 
sitol (1 pM, 300 kBq/nmol) by incubation in an 
about lo-fold volume (w/v) of carbogen saturated 
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(95% 02/5% CO2) Krebs-hydrogen carbonate buf- 
fer (KRB), pH 7.4, as modified in [2], for 150 min 
(37”C, shaking water bath). After washing with 
KRB, muscles were incubated in fresh inositol-free 
buffer, containing 10 mM LiCl and antagonist, if 
necessary. After 10 min, the reaction was started 
by addition of agonist solution and continued for 
30 min. Thereafter, muscles were quickly 
withdrawn, washed twice in ice-cold KRB, blotted 
with filter paper, and freeze-stopped in liquid Nz. 
Tissue was weighed and pulverized in a percussion 
mortar together with a 3-fold volume of water. 
200 mg powder were extracted with 750~1 
CHCWCHsOH (1: 2, v/v) followed by 250 ~1 
water and 250,ul CHC13. After centrifugation 
(8000 x g, 2 min), the radioactivity incorporated 
into lipid and water-soluble metabolites was deter- 
mined (recovery 95 + 2%, n = 8) as described in 
PI. 
Flexor digitorum brevis muscle fibers were 
prepared essentially as described in [7]. After in- 
cubation of muscles in KRB for 200 min with 
[‘Hlinositol (1 PM, 600 kBq/nmol), collagenase 
(0.5 U/ml), and ampicillin (0.1 mg/ml), a crude 
single cell suspension was obtained by trituration 
with a Pasteur pipette. The suspension was washed 
four times with KRB by centrifugation (15 x g, 
90 s). Thus, an about lOOO-fold enrichment of 
fibers in relation to the mononuclear cells was ob- 
tained. As determined by trypan blue exclusion, 
the viability of fibers was largely maintained (60%) 
cf. [7]). 0.2 ml of enriched fiber suspension (about 
5 x lo4 fibers/ml) was mixed with 10~1 of LiCl 
solution (0.2 M) containing antagonist, if 
necessary, and further incubated, as described 
above. The reaction was terminated and extraction 
performed exactly as described for muscle powder. 
Tissue water content (81.6 t- 1 .O%, n = 16) was 
determined in separate experiments and remained 
unaffected by epinephrine treatment. Glucose 
6-phosphate content of incubated hemidiaphragms 
was enzymatically determined in perchloric acid 
extracts [8]. Production of CAMP in membrane 
preparations of enriched fiber suspensions was 
estimated as given in [9]. 
3. RESULTS 
Incorporation of radioactivity from 1 ,xM 
[3H]inositol into lipid and water-soluble muscle 
metabolites increased at an essentially constant 
rate up to 4 h of incubation. Similar results were 
obtained in 3-h incubations with [3H]inositol from 
1 to 80pM (not shown). Thus, standard prelabel- 
Table 1 
Effect of various adrenergic agonists on [3H]inositol monophosphate accumulation in 
incubations of prelabelled rat hemidiaphragms with LiCl 
Condition [3H]Inositol monophosphate accumulation 
(dpm/mg dry wt) 
- Phentolamine Prazosin Propranolol 
(10 PM) (1 PM) (10,4M) 
Control 
Epinephrine (10 PM) 
Norepinephrine (10 ,uM) 
Phenylephrine (10 PM) 
Isoprenaline (1 PM) 
101 f 15 118 f 35 125 f 35 110 f 13 
809 f 194 156 f 26 140 + 9 688 f 108 
694 f 96 157 * 31 n.d. n.d. 
444 + 130 100 f 14 108 + 14 515 f 46 
94+ 8 124 f 35 121 k 38 110 f 12 
Hemidiaphragms were prelabelled by incubation with [3H]inositol. 10 mM LiCl and 
antagonist in fresh medium were applied 10 min prior to a 30-min treatment with 
agonist. The reaction was terminated by freeze-stopping of tissue in liquid Nz. Water- 
soluble metabolites were extracted and radioactivity incorporation determined after 
anion chromatographic separation (see section 2 for details). The concentrations of 
drugs were as indicated. Results are means k SD from 3-14 separate incubations; n.d., 
not determined 
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ling conditions were deliberately chosen to obtain 
sufficient incorporation of radioactivity for 
reliable measurements. In incubations of prela- 
belled hemidiaphragms in the absence of LiCl, 
radioactivity was recovered in phosphatidylino- 
sitol, glycerophosphoinositol, inositol tris-, bis- 
and monophosphate (Ins-P) fractions and amount- 
ed to 2561 + 564, 49 + 11, 28 + 11, 44 + 17 and 
36 + 3 dpm/mg dry wt (n = g), respectively. With 
LiCl, given exclusively or in combination with 
other drugs, only the increase of radioactivity in 
Ins-P proved to be statistically significant (r, C 
0.001 by Student’s t-test). 
The effects of various agonists and antagonists 
are shown in table 1. Ins-P accumulation in 
hemidiaphragms was considerably stimulated by 
o-agonists. As tested with epinephrine, this was 
due to a linear increase over the 30-min incubation 
period (not shown). Stimulation was totally in- 
hibited in the presence of a-antagonists. In con- 
trast, neither &agonists nor &antagonists had any 
effect. 
In comparative experiments with intact flexor 
digitorum brevis muscles, prelabelled for 150 min, 
Fig.1. Effect of adrenergic stimulation on [3H]inositol 
monophosphate accumulation (Ins-P) in incubations of 
prelabelled flexor digitorum brevis muscle fibers with 
LiCI. Muscles were incubated with [3H]inositol and 
collagenase and enriched fiber suspensions prepared as 
detailed in section 2. 10 mM LiCl and 10pM 
phentolamine (Pta) were applied 10 min prior to a 
30-min treatment with epinephrine (Epi, 1OpM). 
Extraction and chromatographic separation of [3H]Ins- 
P were performed as given in section 2. Results 
(means f SD of triplicate samples) of one experiment, 
Fig.2. Effect of catecholamines on CAMP production in 
membrane preparations of isolated flexor digitorum 
brevis muscle fibers. Enriched fiber suspensions were 
prepared as given in the legend to fig.1, but the tritium 
label was omitted. Membranes were prepared and 
assayed for adenylate cyclase activity in lo-min 
incubations according to [9] in the absence (control) or 
presence of hormone (10 pM): isoprenaline, Iso; 
epinephrine, Epi; norepinephrine, Nor. The effect of 
forskolin (For, 33 PM) is included for comparison. 
[32P]cAMP formation was calculated on the basis of the 
specific radioactivity of [~u-~*P]ATP in the assays. 
Means + SD of quadruplicate samples from one 
typical for three, are shown. experiment, typical of two, are shown. 
phenylephrine induced a 4.2 + 0%fold increase in 
Ins-P (n = 4). This corresponded to the data for 
hemidiaphragms (cf. table 1). 
Whether a-agonist effects were actually due to 
hormonal regulation of striated muscle metabo- 
lism, was examined with prelabelled fiber prepara- 
tions which were virtually free from mononuclear 
cells. In fact, epinephrine induced a 2-3-fold in- 
crease in Ins-P formation (2.0 + 0.3-fold in crude 
preparations, n = 3) which could be completely 
blocked by the a-antagonist phentolamine (fig. 1). 
&Receptor-mediated regulation was examined 
by treatment of incubated diaphragms with 10 ,uM 
epinephrine for 10 min. Glucose 6-phosphate con- 
tent was 0.23 + 0.02 pmol/g of muscle wet wt com- 
pared to 0.09 + 0.01 and 0.07 f O.O2/1mol/g in 
controls and in the presence of 10 PM propranolol, 
respectively (n = 3). As is shown in fig.2, in mem- 
brane preparations of isolated muscle fibers, ,8- 
agonists induced a several fold increase of CAMP 
formation. 
Is0 Epi NW For 
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4. DISCUSSION 
It was the aim of the present study to establish 
whether or not catecholamines might influence dif- 
ferentiated skeletal muscle phosphoinositide turn- 
over. Taken together, the present results suggest 
that in the rat (i) catecholamines are involved and 
(ii) effects are mediated by cYi-receptors. This is 
compatible with the results of a recent investiga- 
tion, in which the occurrence of &r-receptors in 
skeletal muscle could be demonstrated, whereas 
a2-receptors were apparently absent [lo]. 
In prelabelled rat hemidiaphragms, epinephrine- 
induced accumulation of Ins-P was linear for 
30 min, and slight increases of radioactivity in the 
Ins-P3 fraction were found, even after short hor- 
mone treatment in the minute range. Whether Ins- 
P accumulation was actually a consequence of 
cur-receptor-mediated nhancement of Ins-P3 for- 
mation, as has been proposed for rat heart [6], re- 
mains to be established. The present experiments 
provided no conclusive, i.e. statistically signifi- 
cant, results, presumably due to some experimen- 
tal limitations, e.g. impossibility of reaching a 
steady state in phospholipid labelling, variation of 
data and, possibly, small changes in intracellular 
Ins-P3 steady-state concentrations. 
Catecholamine-induced increase in Ins-P3 
seems, however, an attractive possibility, as in 
skeletal muscle, Ins-P3 might be involved in 
excitation-contraction coupling [ 1 l] and has been 
suggested to increase Ca2+ sensitivity of the con- 
tractile apparatus [ 121. 
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